Breast cancer survival among young women: a review of the role of modifiable lifestyle factors
暂无分享,去创建一个
Ivo A. Olivotto | Darren R. Brenner | Julia A. Knight | Christine M. Friedenreich | Michelle Cotterchio | Kerry S. Courneya | May Lynn Quan | Nigel T. Brockton | Joanne Kotsopoulos | Beatrice A. Boucher
[1] Sameer M. Siddiqi,et al. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. , 2012, Journal of the National Cancer Institute.
[2] B. Rasmussen,et al. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark. , 2011, Journal of the National Cancer Institute.
[3] Young-In Kim. Does a high folate intake increase the risk of breast cancer? , 2006, Nutrition reviews.
[4] C. Rock,et al. Dietary Intake, Supplement Use, and Survival Among Women Diagnosed With Early-Stage Breast Cancer , 2011, Nutrition and cancer.
[5] C. Friedenreich,et al. Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. , 2014, Medicine and science in sports and exercise.
[6] S. Dickerson,et al. Diurnal cortisol rhythm and fatigue in breast cancer survivors , 2005, Psychoneuroendocrinology.
[7] R Peto,et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.
[8] A. Ray,et al. Obesity and breast cancer: status of leptin and adiponectin in pathological processes , 2010, Cancer and Metastasis Reviews.
[9] R. Schreiber,et al. Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.
[10] J. Manivel,et al. A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. , 2001, The American journal of pathology.
[11] A. Folsom,et al. NSAID use and survival after breast cancer diagnosis in post-menopausal women , 2006, Breast Cancer Research and Treatment.
[12] H Putter,et al. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. , 2006, European journal of cancer.
[13] C. McCowan,et al. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study , 2014, British Journal of Cancer.
[14] J. Chang-Claude,et al. Serum enterolactone and prognosis of postmenopausal breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Kathleen A Cronin,et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. , 2014, Journal of the National Cancer Institute.
[16] A. Wolk,et al. Folate intake and breast cancer mortality in a cohort of Swedish women , 2012, Breast Cancer Research and Treatment.
[17] J. Isola,et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. , 2002, Cancer research.
[18] A. Ziogas,et al. Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer. , 2009, Cancer epidemiology.
[19] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[20] J. Palmer,et al. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health study , 2011, BMC complementary and alternative medicine.
[21] S. Edge,et al. Pretreatment Serum Concentrations of 25-Hydroxyvitamin D and Breast Cancer Prognostic Characteristics: A Case-Control and a Case-Series Study , 2011, PloS one.
[22] C. Shriver,et al. Impact of lifestyle factors on prognosis among breast cancer survivors in the USA , 2012, Expert review of pharmacoeconomics & outcomes research.
[23] M. Somerfield,et al. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] B. Sternfeld,et al. Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project , 2011, Breast Cancer Research and Treatment.
[25] Umberto Veronesi,et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.
[26] D. Grabrick,et al. High-Folate Diets and Breast Cancer Survival in a Prospective Cohort Study , 2002, Nutrition and cancer.
[27] S. Barni,et al. Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary report. , 1991, Oncology.
[28] I. Henderson,et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials: Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (Clinical Trial Service Unit (CTSU), Oxford, UK) Lancet 379:432-444, 2012§ , 2013 .
[29] K. Gelmon,et al. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort. , 2014, International journal of radiation oncology, biology, physics.
[30] J. Hoek,et al. Mechanisms of alcohol-induced tissue injury. , 2003, Alcoholism, clinical and experimental research.
[31] D. Gaffney,et al. In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. , 2015, International journal of radiation oncology, biology, physics.
[32] C. Rock,et al. Soy Food Consumption and Breast Cancer Prognosis , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[33] A. Cheung,et al. Perimenopausal and Postmenopausal Health , 2004, BMC women's health.
[34] V. Shavers,et al. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 , 2003, Cancer.
[35] P. Watson,et al. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer , 2011, Breast Cancer Research.
[36] I. Tentes,et al. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism. , 2008, Neoplasma.
[37] I. Olivotto,et al. Declining Use of Mastectomy for Invasive Breast Cancer in Canada, 1981–2000 , 2004, Canadian journal of public health = Revue canadienne de sante publique.
[38] S. Seal,et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.
[39] M. Cotterchio,et al. Phytoestrogen Content of Foods Consumed in Canada, Including Isoflavones, Lignans, and Coumestan , 2006, Nutrition and cancer.
[40] Duane D. Miller,et al. The role of vitamin D in cancer prevention. , 2015, Chinese journal of natural medicines.
[41] D F Dinges,et al. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. , 2001, The Journal of allergy and clinical immunology.
[42] Heike Knüpfer,et al. Significance of interleukin-6 (IL-6) in breast cancer (review) , 2007, Breast Cancer Research and Treatment.
[43] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[44] R. Peto,et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. , 2012, Lancet.
[45] P. Vertino,et al. Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes , 2010, Cancer.
[46] Young-In Kim. Role of folate in colon cancer development and progression. , 2003, The Journal of nutrition.
[47] R. Coates,et al. Recreational physical activity and survival among young women with breast cancer , 2006, Cancer.
[48] F. Hu,et al. Are Diet Quality Scores After Breast Cancer Diagnosis Associated with Improved Breast Cancer Survival? , 2013, Nutrition and cancer.
[49] D. Wheeler,et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.
[50] L. Bernstein,et al. Exercise activity, body size and premenopausal breast cancer survival , 2004, British Journal of Cancer.
[51] J. Levy,et al. Use and abuse of HOMA modeling. , 2004, Diabetes care.
[52] J. Beilby,et al. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. , 2006, Annals of epidemiology.
[53] E. Giovannucci,et al. Role of vitamin and mineral supplementation and aspirin use in cancer survivors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] F. Queiroga,et al. A Role for T-Lymphocytes in Human Breast Cancer and in Canine Mammary Tumors , 2014, BioMed research international.
[55] R. Aft,et al. Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancer , 2009, Journal of surgical oncology.
[56] Ian O Ellis,et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] J. Mullington,et al. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. , 2007, Sleep.
[58] M. Pike,et al. Epidemiology of soy exposures and breast cancer risk , 2008, British Journal of Cancer.
[59] G. Neuner,et al. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. , 2011, International journal of radiation oncology, biology, physics.
[60] A. Miller,et al. Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size , 2004, Breast Cancer Research and Treatment.
[61] F. Cardoso,et al. First international consensus guidelines for breast cancer in young women (BCY1). , 2014, Breast.
[62] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[63] N. Parekh,et al. Dietary fat in breast cancer survival. , 2013, Annual review of nutrition.
[64] A. Ray,et al. Effects of adiponectin on breast cancer cell growth and signaling , 2008, British Journal of Cancer.
[65] W. Willett,et al. Plasma adiponectin concentrations and risk of incident breast cancer. , 2006, The Journal of clinical endocrinology and metabolism.
[66] C. Mantzoros,et al. Relationship of Plasma Adiponectin With Sex Hormone and Insulin‐like Growth Factor Levels , 2007, Obesity.
[67] C. Denny,et al. Alcohol use among pregnant and nonpregnant women of childbearing age - United States, 1991-2005. , 2009, MMWR. Morbidity and mortality weekly report.
[68] C. Quesenberry,et al. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study , 2009, Breast Cancer Research and Treatment.
[69] Carsten Denkert,et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] S. Narod. BRCA mutations in the management of breast cancer: the state of the art , 2010, Nature Reviews Clinical Oncology.
[71] M. Cotterchio,et al. Dietary Phytoestrogens, Including Isoflavones, Lignans, and Coumestrol, in Nonvitamin, Nonmineral Supplements Commonly Consumed by Women in Canada , 2007, Nutrition and cancer.
[72] C. Ulrich,et al. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] Lori Minasian,et al. The Role of Obesity in Cancer Survival and Recurrence , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[74] N. Gebruers,et al. Late effects of cancer treatment in breast cancer survivors , 2015, South Asian Journal of Cancer.
[75] Jan Born,et al. Sleep and immune function , 2011, Pflügers Archiv - European Journal of Physiology.
[76] P. Hall,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.
[77] Alberto Mantovani,et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.
[78] C. Anders,et al. Breast cancer in adolescents and young adults: a review with a focus on biology. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.
[79] Y.-I. Kim,et al. Folate: a magic bullet or a double edged sword for colorectal cancer prevention? , 2006, Gut.
[80] B. Trock,et al. Meta-analysis of soy intake and breast cancer risk. , 2006, Journal of the National Cancer Institute.
[81] C. Rubino,et al. Increased risk of second cancers following breast cancer: Role of the initial treatment , 2000, Breast Cancer Research and Treatment.
[82] J. Mullington,et al. Sleep loss and inflammation. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[83] A. Bleyer,et al. Breast cancer before age 40 years. , 2009, Seminars in oncology.
[84] A. Green,et al. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin‐8 as a potential regulatory factor in breast tumours , 1997, International journal of cancer.
[85] J. Chang-Claude,et al. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status , 2012, International journal of cancer.
[86] S. Edge,et al. Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[87] A. Neugut,et al. B-Vitamin Intake, One-Carbon Metabolism, and Survival in a Population-Based Study of Women with Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[88] S. Hankinson,et al. Plasma Vitamin D Levels, Menopause, and Risk of Breast Cancer , 2013, Medicine.
[89] R. Wu,et al. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. , 2013, Asian Pacific Journal of Cancer Prevention.
[90] D. Cutter,et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials , 2012, The Lancet.
[91] P. Watson,et al. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR) , 2011, Breast cancer : basic and clinical research.
[92] Hong-Bin Kang,et al. Positive effects of soy isoflavone food on survival of breast cancer patients in China. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[93] L. Qin,et al. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies , 2010, Breast Cancer Research and Treatment.
[94] J. Peterse,et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[95] M. Irwin. Depression and Insomnia in Cancer: Prevalence, Risk Factors, and Effects on Cancer Outcomes , 2013, Current Psychiatry Reports.
[96] J. Chang-Claude,et al. Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[97] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[98] J. Blay,et al. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients , 2003, British Journal of Cancer.
[99] E. Bar-Meir,et al. Second international consensus guidelines for breast cancer in young women (BCY2). , 2014, Breast.
[100] D. Dimitrov,et al. Folate receptor‐β constitutes a marker for human proinflammatory monocytes , 2014, Journal of leukocyte biology.
[101] J. Palmer,et al. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. , 2005, American journal of epidemiology.
[102] EBCTCG (Early Breast Cancer Trialists' Collaborati. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.
[103] K. Skinner,et al. The Association Between Breast Cancer Prognostic Indicators and Serum 25-OH Vitamin D Levels , 2012, Annals of Surgical Oncology.
[104] M. Keyes,et al. Is mastectomy superior to breast-conserving treatment for young women? , 2007, International journal of radiation oncology, biology, physics.
[105] D. Jeffe,et al. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. , 2009, Journal of the American College of Surgeons.
[106] I. Soerjomataram,et al. Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. , 2005, European journal of cancer.
[107] D. Rose,et al. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. , 2007, Endocrine-related cancer.
[108] C. Ulrich,et al. Associations of serum 25-hydroxyvitamin D with overall and breast cancer–specific mortality in a multiethnic cohort of breast cancer survivors , 2013, Cancer Causes & Control.
[109] N. Lunet,et al. Impact of breast cancer treatments on sleep disturbances - A systematic review. , 2014, Breast.
[110] Irmtraud M. Meyer,et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.
[111] J. Chang-Claude,et al. Meta-analyses of lignans and enterolignans in relation to breast cancer risk. , 2010, The American journal of clinical nutrition.
[112] A. McTiernan,et al. Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[113] Young-In Kim. Folic acid fortification and supplementation--good for some but not so good for others. , 2007, Nutrition reviews.
[114] A. Bleyer,et al. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. , 2006 .
[115] Young-In Kim. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[116] M. Ramos-Nino. The Role of Chronic Inflammation in Obesity-Associated Cancers , 2013, ISRN oncology.
[117] I. Tentes,et al. Significance of Serum Tumor Necrosis Factor-Alpha and its Combination with Her-2 Codon 655 Polymorphism in the Diagnosis and Prognosis of Breast Cancer , 2010, The International journal of biological markers.
[118] L. Dogliotti,et al. Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. , 2011, The oncologist.
[119] M. Coory,et al. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.
[120] H. Abdul-Jabar,et al. Alcohol and Breast Cancer: The Mechanisms Explained , 2009, Journal of clinical medicine research.
[121] G. Colditz,et al. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin , 2011, Breast Cancer Research and Treatment.
[122] J. Marks,et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] J. Pierce. Diet and breast cancer prognosis: making sense of the Women's Healthy Eating and Living and Women's Intervention Nutrition Study trials , 2009, Current opinion in obstetrics & gynecology.
[124] V. Kosma,et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer. , 1992, European journal of cancer.
[125] Yan Zhu,et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. , 2004, The American journal of clinical nutrition.
[126] A. Leathem,et al. Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies , 2009, British Journal of Cancer.
[127] H. Honoré,et al. Breast cancer in young women. , 1979, British medical journal.
[128] V. Livolsi. Anti-metastatic effect of aspirin. , 1973, Lancet.
[129] A. Luini,et al. Breast-conserving surgery in 201 very young patients (<35 years). , 2010, Breast.
[130] C. Geyer,et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[131] L. Holmberg,et al. Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment , 2009, PloS one.
[132] Haifa Dbouk,et al. Epidemiology and prognosis of breast cancer in young women. , 2013, Journal of thoracic disease.
[133] J. Carroll,et al. Bone health issues in breast cancer survivors: a Medicare Current Beneficiary Survey (MCBS) study , 2013, Supportive Care in Cancer.
[134] C. Sotiriou,et al. Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling , 2012, Clinical Cancer Research.
[135] S. Swain,et al. Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems , 2008, Clinical Cancer Research.
[136] X. Shu,et al. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. , 2012, The American journal of clinical nutrition.
[137] P. Rothwell,et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials , 2012, The Lancet.
[138] J. Stagg,et al. Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects , 2013, Therapeutic advances in medical oncology.
[139] P. Goodwin,et al. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[140] B. Shane. Folate fortification: enough already? , 2003, The American journal of clinical nutrition.
[141] G. Nagaraju,et al. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. , 2013, Nutrition reviews.
[142] J. Overgaard,et al. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[143] S. Narod,et al. Folate and breast cancer: what about high-risk women? , 2012, Cancer Causes & Control.
[144] Marilie D. Gammon,et al. Breast cancers among very young premenopausal women (United States) , 2003, Cancer Causes & Control.
[145] R. Hayes,et al. Cancer Causes & Control , 2004, Cancer Causes & Control.
[146] Qingyuan Zhang,et al. Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy , 2010, Canadian Medical Association Journal.
[147] S. Gomez,et al. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. , 2014, JAMA.
[148] C. Ulrich,et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[149] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[150] W. Willett,et al. Diet Quality Indices and Postmenopausal Breast Cancer Survival , 2011, Nutrition and cancer.
[151] E. van Limbergen,et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. , 2015, The Lancet. Oncology.
[152] W. Willett,et al. Dietary factors and the survival of women with breast carcinoma , 1999, Cancer.
[153] David W. Dunstan,et al. Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003–2006) , 2010, Cancer Causes & Control.
[154] A. Ray,et al. Balance of adiponectin and leptin modulates breast cancer cell growth , 2008, Cell Research.
[155] C. Friedenreich. The role of physical activity in breast cancer etiology. , 2010, Seminars in oncology.
[156] M. Lucock,et al. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. , 2000, Molecular genetics and metabolism.
[157] David M. Thomas,et al. The distinctive biology of cancer in adolescents and young adults , 2008, Nature Reviews Cancer.
[158] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[159] I. Ellis,et al. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer , 2007, Genome Biology.
[160] S. Sheps,et al. Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[161] A. Kurian,et al. Occurrence of breast cancer subtypes in adolescent and young adult women , 2012, Breast Cancer Research.
[162] J. Manson,et al. Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women. , 2014, The Journal of nutrition.
[163] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[164] D. de Freitas,et al. [Alcohol and cancer]. , 1997, Acta medica portuguesa.
[165] Shailesh Agarwal,et al. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. , 2014, JAMA surgery.
[166] X. Shu,et al. Soy food intake and breast cancer survival. , 2009, JAMA.
[167] A. Cooke,et al. Immunity, Transferrin, and Survival in Kwashiorkor , 1970, British medical journal.
[168] C. Rock,et al. Diet and risk for breast cancer recurrence and survival , 1999, Breast Cancer Research and Treatment.
[169] A. Neugut,et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[170] J. Ray. Folic acid food fortification in Canada. , 2004, Nutrition reviews.
[171] M. Irwin,et al. Sleep disturbance, inflammation and depression risk in cancer survivors , 2013, Brain, Behavior, and Immunity.
[172] N. Parekh,et al. Obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors. , 2009, Journal of the American Dietetic Association.
[173] E. Lee,et al. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study , 2011, Breast Cancer Research.
[174] Chaoming Mao,et al. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis , 2014, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[175] R. Baumgartner,et al. Associations of insulin resistance and adiponectin with mortality in women with breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[176] C. Stewart,et al. Antimetastatic effects associated with platelet reduction. , 1968, Proceedings of the National Academy of Sciences of the United States of America.
[177] J. Vilcoq,et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.
[178] E. Ostrander,et al. Frequency of BRCA1/BRCA2 mutations in a population‐based sample of young breast carcinoma cases , 2000, Cancer.
[179] C. Ulrich,et al. Postdiagnosis Diet Quality Is Inversely Related to a Biomarker of Inflammation among Breast Cancer Survivors , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[180] Early Breast Cancer Trialists' Collaborative Group. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.
[181] Young-In Kim. Folate and colorectal cancer: an evidence-based critical review. , 2007, Molecular nutrition & food research.
[182] Daniel Birnbaum,et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. , 2006, Cancer research.
[183] W. Woodward,et al. Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype. , 2011, Clinical breast cancer.
[184] C. Friedenreich. Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. , 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[185] Garret A. FitzGerald,et al. Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[186] D. Hicks,et al. Folate receptor α associated with triple-negative breast cancer and poor prognosis. , 2014, Archives of pathology & laboratory medicine.
[187] H. Putter,et al. COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients , 2011, Breast Cancer Research and Treatment.
[188] D. Rose,et al. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[189] L. Habel,et al. NSAIDs and breast cancer recurrence in a prospective cohort study , 2007, Cancer Causes & Control.
[190] X. Chen,et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.
[191] A. Bertolotti,et al. Host Resistance in Relation to Survival in Breast Cancer , 1974, British medical journal.
[192] B. E. F. Isher,et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .
[193] Ya-li Liu,et al. Alcohol Consumption and Breast Cancer Survival: A Meta- analysis of Cohort Studies. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[194] R Peto,et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.
[195] R. Demicheli,et al. Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review , 2013, Current medicinal chemistry.
[196] D. Noh,et al. Prognosis of breast cancer is associated with one-carbon metabolism related nutrients among Korean women , 2012, Nutrition Journal.